Weibo (WB) Ad Load Could Be Growth Lever For Multiple Quarters - Piper
Get Alerts WB Hot Sheet
Rating Summary:
8 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Weibo (NASDAQ: WB) posted strong Q3 results, 2.5% ahead of the Street with Q4 guidance also above the Street. Thematically there are two current keys to the story, Piper Jaffray analyst Gene Munster:
1) the company should continue to see steady margin expansion as revenues ramp
2) the long-term revenue picture is strong given low ad loads compared to US social media companies.
Weibo reported Q3 revenue of $124.7M, 2.5% ahead of the Street at $121.6M and prior guidance for $120-123M. PF EPS was $0.10 vs the Street at $0.03. Monthly active users (MAUs) were 222 million, up 33% y/y vs 36% in Q2 and 38% in Q1. Daily active users (DAUs) were 100 million, up 30% y/y vs up 34% y/y in Q1 and Q2.
Weibo guided Q4 revenue to $146-149M, slightly ahead of the Street's $147M.
The analyst expects WB to grow revenue in the 30-40% range over the next several quarters and considering WB's Q4 guide, he raised Q4 revenue by 7% and 2016 revenue by 4%.
Mobile contributed 64% of total revenue in Q3 vs 62% in Q2, 58% in Q1. Mobile revenue grew 136% y/y in Q3 and accelerated from 134% y/y in Q2.
Weibo management noted that ad load is currently around 2.3%. We note that Facebook has talked about a 5% ad load in the past and have noted an ad load closer to 10% on mobile in our tracking. These US parallels suggest that Weibo can at least double ad load over the next few years.
No change to Overweight rating and PT increases to $23 from $22.
For an analyst ratings summary and ratings history on Weibo Corp click here. For more ratings news on Weibo Corp click here.
Shares of Weibo Corp closed at $17.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- CVS Health (CVS) PT Raised to $110 at BofA Securities
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Piper Jaffray, Gene MunsterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share